Obstetrics & Gynecology Doctors in Jber, AK Accepting Medicare

5 Obstetrics & Gynecology doctors found. Showing 1 - 5

Stephen Alex Kujansuu, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-5808

Meredith Leigh Lane, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-3205

Alecia Hagman, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, 673 Mdg, Jber, AK 99506 Phone: 603-988-5232

Dr. Carrie Lynn Mcbee-cooke, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-4020

Dr. Amanda Killinger, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 673 Mdg/usaf, 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-5808

News Archive

Washington Times examines how U.S. assesses corruption in aid recipient countries

The Washington Times continues its coverage of the challenges facing the U.S. Millennium Challenge Corporation (MCC) - "the U.S. government agency that provides large-scale grant to … chosen countries to reduce poverty and stimulate economic growth. … Although MCC says control of corruption is the single most important indicator by which a nation is deemed qualified for aid money, a review of the State Department's most recent report on human rights reveals that … virtually every country receiving similar grants - has been criticized for government corruption."

Varian, Flatiron Health partner to develop next generation of cloud-based software for cancer care providers

Varian Medical Systems and Flatiron Health today announced a strategic alliance to develop the next generation of cloud-based, electronic health record (EHR), data analytics and decision support software for cancer care providers around the world.

Genzyme ranked third on the global list for best employers

Genzyme Corporation announced today that scientists have again named the company a top employer in a survey ranking the reputations of biotechnology and pharmaceutical companies. Genzyme is ranked third on the global list of 575 companies, the second consecutive year it has achieved this position. Genzyme placed among the top 10 of all biotechnology and pharmaceutical companies in the world for the seventh year in a row.

Special issue of Neuron journal provides new insight into recent advances in addiction research

Addiction is a brain disease that destroys lives, devastates families and tears at the very fabric of society. Effective prevention and treatment of addiction requires a clear understanding of the complex brain mechanisms that underlie addictive behaviors, and research has provided a fascinating view of how substance abuse hijacks neuronal circuits involved in reward and motivation and causes profound and persistent changes in behavior.

Zymeworks, ImClone Systems partner to develop novel bi-specific antibody oncology therapeutics

Zymeworks Inc. today announced that it has entered into a licensing and collaboration agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to develop an undisclosed number of novel bi-specific antibody oncology therapeutics using Zymeworks' proprietary Azymetric platform. Bi-specific antibodies have the potential to provide improved outcomes for patients by simultaneously targeting two tumor associated antigens to induce a synergistic therapeutic response.

Read more Medical News

› Verified 7 days ago